Delivery Order SPE2DB24D1104-SPE2DB26FXTF7
Award Date 10/16/25
Potential Completion Date 10/17/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies, valued at $1,500.30 with an ultimate completion date of October 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $1,800.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for Xyosted 75 mg/0.5 mL auto-injector vials. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a...
- The Defense Logistics Agency awarded a $2,205.54 delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injectors on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injection, representing part of the...
- The Defense Logistics Agency awarded a $1,752.22 delivery order to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injectors on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. Xyosted is a testosterone replacement therapy medication delivered via auto-injector, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,755.76 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies. This non-set-aside, firm fixed-price delivery order was executed on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product used in military and federal healthcare settings to support...
- The Defense Logistics Agency awarded a $1,317.52 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for Xyosted 50 mg/0.5 mL auto-injector units with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, supporting the agency's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,850.37 for the supply of Xyosted 100 mg/0.5 mL auto-injector units on August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was completed with an ultimate completion date of August 28, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy medication...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,444.99 on June 3, 2025, for the supply of Xyosted 100 mg/0.5 ml auto-injectors (0.5 ml). This firm fixed-price, competitively awarded delivery order is scheduled for ultimate completion on June 4, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible vendors. Xyosted is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with a ceiling value of $1,314.73 under a firm fixed-price arrangement. The contract was competitively awarded without set-aside provisions and is due for completion by September 9, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,293.84 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. The contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same municipality....